Phosphodiesterase-5 inhibitors: clinical market and basic science comparative studies
- PMID: 15541215
- DOI: 10.1007/s11934-004-0070-2
Phosphodiesterase-5 inhibitors: clinical market and basic science comparative studies
Abstract
The purpose of this review is to examine the biologic, pharmacologic, and clinical differences between the three currently approved phosphodiesterase-5 inhibitors to help the clinician make an educated choice about which medication may be best for any individual patient.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical